{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:25:40Z","timestamp":1787765140903,"version":"build-2784847793"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.4103\/ijd.ijd_1061_20","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T05:02:53Z","timestamp":1704776573000},"page":"698-700","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dose-Adjusted FRAX Score in Pemphigus Vulgaris Treatment"],"prefix":"10.4103","volume":"68","author":[{"given":"Sa\u00fal","family":"Guzm\u00e1n-Herrera","sequence":"first","affiliation":[{"name":"From the Research and Education Unit, Centro Dermatol\u00f3gico \u201cDr. Ladislao de la Pascua\u201d, Dr. Jos\u00e9 Mar\u00eda Vertiz 464, Buenos Aires, Cuauht\u00e9moc, Ciudad de M\u00e9xico, Mexico E-mail: luisa.peraltap@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Morales-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"From the Research and Education Unit, Centro Dermatol\u00f3gico \u201cDr. Ladislao de la Pascua\u201d, Dr. Jos\u00e9 Mar\u00eda Vertiz 464, Buenos Aires, Cuauht\u00e9moc, Ciudad de M\u00e9xico, Mexico E-mail: luisa.peraltap@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Peralta-Pedrero","sequence":"additional","affiliation":[{"name":"From the Research and Education Unit, Centro Dermatol\u00f3gico \u201cDr. Ladislao de la Pascua\u201d, Dr. Jos\u00e9 Mar\u00eda Vertiz 464, Buenos Aires, Cuauht\u00e9moc, Ciudad de M\u00e9xico, Mexico E-mail: luisa.peraltap@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"de Pe\u00f1a-Ortiz","sequence":"additional","affiliation":[{"name":"From the Research and Education Unit, Centro Dermatol\u00f3gico \u201cDr. Ladislao de la Pascua\u201d, Dr. Jos\u00e9 Mar\u00eda Vertiz 464, Buenos Aires, Cuauht\u00e9moc, Ciudad de M\u00e9xico, Mexico E-mail: luisa.peraltap@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn J. S.","family":"Cruz","sequence":"additional","affiliation":[{"name":"From the Research and Education Unit, Centro Dermatol\u00f3gico \u201cDr. Ladislao de la Pascua\u201d, Dr. Jos\u00e9 Mar\u00eda Vertiz 464, Buenos Aires, Cuauht\u00e9moc, Ciudad de M\u00e9xico, Mexico E-mail: luisa.peraltap@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"R1-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.01.062","article-title":"Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R2-20240829","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"R3-20240829","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaad.2017.04.1116","article-title":"Cumulative oral corticosteroid use increases risk of glucocorticoid-related adverse events in patients with newly diagnosed pemphigus","volume":"77","author":"Wormser","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 2","key":"R4-20240829","first-page":"22","article-title":"[Assessment and intervention thresholds to detect cases at risk of osteoporosis and fragility fractures with FRAX\u00aein a mexican population for the first level of healthcare","volume":"152","author":"Clark","year":"2016","journal-title":"Gac Med Me\u00d7"},{"key":"R5-20240829","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective","volume":"19","author":"Tosteson","year":"2008","journal-title":"Osteoporos Int"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1061_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:00:39Z","timestamp":1787763639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_1061_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_1061_20","relation":{},"ISSN":["0019-5154","1998-3611"],"issn-type":[{"value":"0019-5154","type":"print"},{"value":"1998-3611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"2020-11-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}